Lee Kalowski - 25 Aug 2026 Form 4 Insider Report for Q32 Bio Inc. (QTTB)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
27 Aug 2026, 16:10:05 UTC
Prior SEC filing
20 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Eric Bell, Attorney-in-Fact

Key filing fact

Lee Kalowski filed Form 4 for Q32 Bio Inc. (QTTB) on 27 Aug 2026.

Key facts

  • This page summarizes Lee Kalowski's Form 4 filing for Q32 Bio Inc. (QTTB).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 27 Aug 2026, 16:10.

Change

  • Previous filing in this sequence was filed on 20 Jul 2026.
  • Current net transaction value: -$65,776.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001618273 Primary reporting owner

Kalowski Lee

Relationship
CFO and President
Address
Q32 BIO INC., 830 WINTER STREET, WALTHAM
Signature
/s/ Eric Bell, Attorney-in-Fact
Signature date
27 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QTTB transaction

Common Stock

Sale

Transaction value
$65,776
Shares
-3,972
Change %
-2.8%
Price
$16.56
Shares after
138,471
Date
25 Aug 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .